Previous Close | 0.0055 |
1-Year Change | % |
6-Months Change | % |
3-Months Change | -54.55% |
Moving Avg (50d) | 0.008046 |
Moving Avg (200d) | 0.010839 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.03M |
Beta (3-Years) | |
Revenue Growth (ttm) | 16.89% |
Net Profit Margin (ttm) | -852.8% |
Return On Assets (ttm) | -120.01% |
EPS (ttm) | -1.12 |
PE Ratio (ttm) | - |
Dividend Yield | % |
Asset Description: | Sorrento Therapeutics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-12 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.